A systems biology analysis of lipolysis and fatty acid release from adipocytes in vitro and from adipose tissue in vivo

PLoS One. 2021 Dec 31;16(12):e0261681. doi: 10.1371/journal.pone.0261681. eCollection 2021.

Abstract

Lipolysis and the release of fatty acids to supply energy fuel to other organs, such as between meals, during exercise, and starvation, are fundamental functions of the adipose tissue. The intracellular lipolytic pathway in adipocytes is activated by adrenaline and noradrenaline, and inhibited by insulin. Circulating fatty acids are elevated in type 2 diabetic individuals. The mechanisms behind this elevation are not fully known, and to increase the knowledge a link between the systemic circulation and intracellular lipolysis is key. However, data on lipolysis and knowledge from in vitro systems have not been linked to corresponding in vivo data and knowledge in vivo. Here, we use mathematical modelling to provide such a link. We examine mechanisms of insulin action by combining in vivo and in vitro data into an integrated mathematical model that can explain all data. Furthermore, the model can describe independent data not used for training the model. We show the usefulness of the model by simulating new and more challenging experimental setups in silico, e.g. the extracellular concentration of fatty acids during an insulin clamp, and the difference in such simulations between individuals with and without type 2 diabetes. Our work provides a new platform for model-based analysis of adipose tissue lipolysis, under both non-diabetic and type 2 diabetic conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / metabolism*
  • Adipose Tissue / metabolism*
  • Computer Simulation
  • Cyclic Nucleotide Phosphodiesterases, Type 3 / metabolism
  • Diabetes Mellitus, Type 2 / blood
  • Fatty Acids / blood
  • Fatty Acids / metabolism*
  • Humans
  • In Vitro Techniques
  • Insulin / metabolism
  • Insulin Resistance
  • Lipolysis / physiology*
  • Models, Statistical
  • Models, Theoretical
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt / metabolism
  • Receptors, Adrenergic, alpha-2 / metabolism
  • Receptors, Adrenergic, beta / metabolism
  • Signal Transduction
  • Software
  • Systems Biology*
  • Triglycerides / metabolism
  • Uncertainty

Substances

  • Fatty Acids
  • Insulin
  • Receptors, Adrenergic, alpha-2
  • Receptors, Adrenergic, beta
  • Triglycerides
  • Proto-Oncogene Proteins c-akt
  • Cyclic Nucleotide Phosphodiesterases, Type 3
  • PDE3B protein, human

Grants and funding

PS acknowledges support from Linköping University, the Swedish Diabetes Fund (a 3-years program; https://www.diabetes.se/diabetesfonden/), and the Swedish Research Council (a 5-years program; https://www.vr.se/). EN acknowledges support from the Swedish Research Council (Dnr 2019-03767), the Heart and Lung Foundation (https://www.hjart-lungfonden.se/), CENIIT (20.08; http://ceniit.lith.liu.se/en/), and Åke Wibergs Stiftelse (M19-0449; https://ake-wiberg.se/). GC acknowledges support from the Swedish Research Council (Dnr 2018-05418, 2018-03319), Swedish Foundation for Strategic Research (ITM17-0245; https://strategiska.se/), SciLifeLab and KAW (2020.0182; https://www.scilifelab.se/), Horizon 2020 (PRECISE4Q, 777107; https://ec.europa.eu/programmes/horizon2020/), CENIIT (15.09), ELLIIT (https://www.lu.se/forskning/starka-forskningsmiljoer/strategiska-forskningsomraden/elliit), and the Swedish Fund for Research without Animal Experiments (https://forskautandjurforsok.se/swedish-fund-for-research-without-animal-experiments/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.